Overview

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Status:
Recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.
Phase:
Phase 4
Details
Lead Sponsor:
Psoriasis Treatment Center of Central New Jersey
Collaborator:
Sun Pharmaceutical Industries Limited